Insider Trading Alert - MANH, HSY And TIPT Traded By Insiders

Stocks with insider trader activity include MANH, HSY and TIPT
By TheStreet Wire ,

Yesterday, Nov. 4, 2015, 107 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $85.86 to $4,999,847.37.

Highlighted Stocks Traded by Insiders:

Manhattan Associates (MANH) - FREE Research Report

Cassidy Brian J, who is Director at Manhattan Associates, sold 16,660 shares at $73.83 on Nov. 4, 2015. Following this transaction, the Director owned 106,490 shares meaning that the stake was reduced by 13.53% with the 16,660-share transaction.

The shares most recently traded at $73.31, down $0.52, or 0.7% since the insider transaction. Historical insider transactions for Manhattan Associates go as follows:

  • 4-Week # shares sold: 27,797
  • 12-Week # shares sold: 27,797
  • 24-Week # shares sold: 33,586

The average volume for Manhattan Associates has been 538,900 shares per day over the past 30 days. Manhattan Associates has a market cap of $5.5 billion and is part of the technology sector and computer software & services industry. Shares are up 82.1% year-to-date as of the close of trading on Wednesday.

Manhattan Associates, Inc. develops, sells, deploys, services, and maintains software solutions to manage supply chains, inventory, and omni-channel operations for retailers, wholesalers, manufacturers, logistics providers, and other organizations. The company has a P/E ratio of 57.2. Currently, there are 4 analysts who rate Manhattan Associates a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MANH - FREE

TheStreet Quant Ratings

rates Manhattan Associates as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

Manhattan Associates Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Hershey (HSY) - FREE Research Report

Nevels James E, who is Director at Hershey, sold 1 shares at $88.81 on Nov. 4, 2015. Following this transaction, the Director owned 5,508 shares meaning that the stake was reduced by 0.02% with the 1-share transaction.

The shares most recently traded at $87.81, down $1.00, or 1.14% since the insider transaction. Historical insider transactions for Hershey go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 3,000
  • 24-Week # shares sold: 8,589

The average volume for Hershey has been 1.2 million shares per day over the past 30 days. Hershey has a market cap of $13.8 billion and is part of the consumer goods sector and food & beverage industry. Shares are down 15.61% year-to-date as of the close of trading on Wednesday.

The Hershey Company manufactures, imports, markets, distributes, and sells confectionery products. The company operates through two segments, North America; and International and Other. The stock currently has a dividend yield of 2.65%. The company has a P/E ratio of 39.0. Currently, there are 2 analysts who rate Hershey a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HSY - FREE

TheStreet Quant Ratings

rates Hershey as a

buy

. Among the primary strengths of the company is its respectable return on equity which we feel is likely to continue. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Hershey Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Tiptree Financial (TIPT) - FREE Research Report

Barnes Michael Gene, who is Executive Chairman at Tiptree Financial, bought 5,000 shares at $6.98 on Nov. 4, 2015. Following this transaction, the Executive Chairman owned 3.2 million shares meaning that the stake was boosted by 0.16% with the 5,000-share transaction.

The shares most recently traded at $7.04, up $0.06, or 0.81% since the insider transaction. Historical insider transactions for Tiptree Financial go as follows:

  • 4-Week # shares bought: 41,400
  • 12-Week # shares bought: 122,760
  • 24-Week # shares bought: 291,168

The average volume for Tiptree Financial has been 41,400 shares per day over the past 30 days. Tiptree Financial has a market cap of $229.4 million and is part of the financial sector and insurance industry. Shares are down 13.58% year-to-date as of the close of trading on Wednesday.

TipTree Financial Inc., formerly Care Investment Trust, operates as a real estate investment trust (REIT). It engages in originating and acquiring healthcare-related real estate and commercial mortgage debt. The stock currently has a dividend yield of 1.46%.

Exclusive Offer: Get the latest Stock Analysis on TIPT - FREE

TheStreet Quant Ratings

rates Tiptree Financial as a

sell

. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk, disappointing return on equity, weak operating cash flow, poor profit margins and generally disappointing historical performance in the stock itself. Get the full

Tiptree Financial Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Loading ...